Victor Sung, M.D., director of the Division of Movement Disorders in the University of Alabama at Birmingham Department of ...

An experimental gene therapy slowed Huntington’s by up to 75 percent in a small clinical trial. While not a cure, it may give patients longer lives.

As well as slowing disease progression by 75 percent at 36 months, the scientists found that neurofilament light protein (NfL)—a biomarker of neuronal damage—levels in spinal fluid were lower in ...

An experimental gene therapy has slowed the progression of Huntington’s disease by 75 percent, according to results reported by the biotechnology company uniQure this week.

Huntington’s disease (HD) is a condition that is hereditary and causes nerve cells in specific parts of the brain to slowly ...

Huntington's disease findings were announced last month in a news release from uniQure, the company that sponsored the research.

After years of heartbreak, researchers have found an experimental treatment that can slow the progression of Huntington’s ...

Scientists have slowed the progression of Huntington’s disease for the first time with a “groundbreaking” new treatment. Experts from University College London (UCL) said the finding could “change ...

UCL and uniQure report the first treatment to slow Huntington’s disease with gene therapy AMT-130. High-dose patients had 75% less progression over three years compared with standard care. uniQure ...

Researchers announce breakthrough results for AMT-130, the first disease-modifying treatment for Huntington's disease, with ...

Sex influences how genetic and age-related factors translate into clinical and neuroimaging trajectories in Huntington disease.

Whether the cause is Parkinson’s disease, Huntington’s disease, essential tremor, Tourette’s syndrome or any other condition classified as a movement disorder, it is agonizing for someone to understan ...